{
  "@context": "aku-v2",
  "@type": "definition",
  "@id": "vascular:rare-syndromes:cloves:definition",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T17:21:00.000Z",
    "contributors": ["copilot"],
    "status": "validated",
    "confidence": 0.91
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/rare-syndromes",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "specialized",
    "board_yield": "LOW"
  },
  "content": {
    "term": "CLOVES Syndrome",
    "synonyms": ["Congenital Lipomatous Overgrowth with Vascular malformations, Epidermal nevi, and Scoliosis/Skeletal abnormalities"],
    "definition": "A rare PIK3CA-related overgrowth syndrome characterized by congenital lipomatous overgrowth, complex vascular malformations (capillary, venous, lymphatic, and arteriovenous), epidermal nevi, and skeletal/spinal abnormalities. Part of the PIK3CA-related overgrowth spectrum (PROS).",
    "clinical_features": {
      "lipomatous_overgrowth": [
        "Truncal lipomatous masses (most characteristic)",
        "Progressive overgrowth of adipose tissue",
        "Asymmetric distribution",
        "Present at birth"
      ],
      "vascular_malformations": [
        "Complex combined vascular malformations",
        "Capillary malformations (port-wine stains)",
        "Venous malformations",
        "Lymphatic malformations",
        "High-flow arteriovenous malformations (some cases)"
      ],
      "cutaneous": [
        "Epidermal nevi",
        "Lipomas",
        "Skin tags"
      ],
      "skeletal": [
        "Scoliosis (progressive)",
        "Limb length discrepancy",
        "Macrodactyly",
        "Wide feet with sandal gap",
        "Vertebral anomalies"
      ],
      "neurologic": [
        "Spinal cord compression risk",
        "Tethered cord",
        "Neurologic deficits from paraspinal masses"
      ]
    },
    "pathophysiology": {
      "etiology": "Somatic activating mutations in PIK3CA gene",
      "mechanism": "Hyperactivation of PI3K-AKT-mTOR pathway",
      "inheritance": "Sporadic (somatic mosaicism)",
      "related_conditions": "Part of PIK3CA-related overgrowth spectrum (PROS) with Klippel-Trenaunay, megalencephaly syndromes"
    },
    "diagnosis": {
      "clinical": "Recognition of characteristic phenotype",
      "imaging": "MRI for extent of overgrowth and vascular malformations",
      "genetic": "Detection of PIK3CA mutation in affected tissue (not blood)",
      "differential": "Distinguish from Proteus syndrome, Klippel-Trenaunay syndrome"
    },
    "management": {
      "surveillance": [
        "Regular spinal imaging for scoliosis progression",
        "Monitor for Wilms tumor (slightly increased risk)",
        "Vascular malformation monitoring"
      ],
      "surgical": [
        "Debulking of lipomatous masses",
        "Spinal surgery for severe scoliosis",
        "Vascular malformation treatment as indicated"
      ],
      "pharmacologic": [
        "Alpelisib (PIK3CA inhibitor) - FDA approved for PROS",
        "Sirolimus (mTOR inhibitor) - off-label use"
      ]
    }
  },
  "codes": {
    "snomed_ct": "720864008",
    "icd_10": "Q87.3",
    "orphanet": "140944"
  },
  "relationships": {
    "broader": ["vascular:malformations:combined-syndromes", "genetics:pik3ca-spectrum"],
    "related": ["vascular:malformations:klippel-trenaunay", "vascular:rare-syndromes:proteus"],
    "narrower": []
  },
  "pedagogical": {
    "learning_objectives": [
      "Recognize CLOVES syndrome phenotype",
      "Understand PIK3CA-related overgrowth spectrum",
      "Know emerging targeted therapies"
    ],
    "clinical_pearls": [
      "Truncal lipomatous overgrowth is the hallmark feature",
      "Part of PIK3CA-related overgrowth spectrum (PROS)",
      "Alpelisib is first FDA-approved targeted therapy for PROS",
      "Genetic testing requires affected tissue, not blood"
    ]
  }
}
